Prescription

• The Connecticut Office of Health Strategy (OHS) has released a preliminary list of outpatient prescription drugs provided at a substantial cost for the 2026 reporting cycle. • The report details the highest-cost outpatient drugs, including total costs, utilization rates across commercial, Medicaid, and Medicare Advantage markets, and wholesale acquisition cost increases. • This initiative, mandated by Connecticut General Statute § 19a-754b (d), aims to increase transparency regarding the pricing and accessibility of expensive medications.

Trump claims number of medications available via the discount program will increase nearly sevenfoldDonald Trump has announced a major expansion of his prescription drug website, TrumpRx, claiming the number of medications available via the discount program will increase nearly sevenfold.Experts raised questions earlier this year about the limited number of drugs listed on the site, suggesting they would appeal to a relatively small group of patients. Continue reading...

• President Donald Trump outlined sweeping healthcare reforms in an Oval Office address, announcing what he described as the largest prescription drug price cuts in U.S. history. • The announcement represents a major domestic policy initiative focused on reducing medication costs for American consumers. • Trump simultaneously signaled potential progress in Iran conflict negotiations, suggesting possible diplomatic breakthroughs as ceasefire talks continue.

• Centers for Medicare and Medicaid Services published a proposed rule on Friday requiring health insurance companies and states to resolve non-urgent prior authorization requests for prescription drugs within 24 hours. • The regulation mandates Medicaid and CHIP insurers, plus state administrators, to publicly disclose denial rates and respond faster to improve patient access. • This addresses delays in medication approvals, potentially benefiting millions enrolled in these programs amid ongoing affordability challenges.